ReviewBreast cancer (Dove Medical Press)2017

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib.

Dumessa Edessa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.